文献速递免疫规划卫生政策与健康促进

荷兰政府疫苗接种项目支出的历史趋势分析

Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis.
PubMed 文献 · Vaccine · 2019-08-13

该研究回顾了荷兰国家免疫规划(NIP)和流感疫苗接种的财务历史,将支出按2016年欧元调整通胀后与人口、宏观经济及避免的死亡负担比较。

核心结论

  • 虽然疫苗接种项目支出大幅增加,但其占整体医疗支出的比例仍然很小。
  • 每获得一年寿命的实际成本比本估算更有利,因为未包括避免的医疗费用。

研究设计与样本

  • 历史分析,从官方报告中获取荷兰国家免疫规划(NIP)和流感疫苗接种的未编目历史支出数据。
  • 成本使用消费者价格指数调整通胀,以2016年欧元表示。
  • 避免的死亡负担估计来自先前研究,用于计算1953-1992年出生队列白喉、破伤风、百日咳、脊髓灰质炎、麻疹、腮腺炎和风疹疫苗接种的支出与避免死亡负担的比率。

主要发现

  • 20世纪50年代初开始走向统一政府资助的NIP,进行白喉、百日咳和破伤风疫苗接种,1957年与脊髓灰质炎疫苗接种一起正式启动。
  • 自1980年代以来,支出增加近五倍,主要由于新增疫苗,而已实施疫苗的支出趋于下降。
  • NIP占医疗总支出比例较小,范围在0.05%至0.14%之间。

关键数值与推荐

  • NIP占医疗总支出0.05%-0.14%。
  • 2014年疫苗接种项目占医疗支出0.15%,每出生人口支出533欧元。

临床怎么用

  • 卫生经济评估在实施疫苗接种项目前常被要求,但很少考虑项目的历史背景。
  • 疫苗接种项目支出占医疗总支出比例小,可为政策制定提供参考。

局限性

  • 每获得一年寿命的实际成本比本估算更有利,因为未包括避免的医疗费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health economic evaluations are often required before implementing a vaccination programme. Such evaluations rarely consider the historical context of a vaccination programme. We review the financial history of vaccination programmes in the Netherlands, and compare these to demographic and macroeconomic developments as well as avoided mortality burden. METHODS: Previously uncatalogued historical expenditures on the Dutch National Immunisation Programme (NIP) and influenza vaccination were obtained from official reports. Costs were adjusted for inflation using Consumer Price Indices and expressed in Euro of 2016. Estimates on mortality burden averted were obtained from previous research and used to calculate the ratio of expenses to averted mortality burden for vaccinations against diphtheria, tetanus, pertussis, polio, measles, mumps and rubella for birth cohorts 1953-1992. RESULTS: Developments towards a uniform government funded NIP started early 1950s with vaccinations against diphtheria, pertussis and tetanus, culminating in its official launch in 1957 together with polio vaccinations. Since the 1980s, expenditure increased nearly five-fold mostly due to the addition of new vaccines, while spending on already implemented vaccinations tended to decline. Overall, expenditure increased from € 5 million in 1957 to € 93 million in 2014. Relative to total healthcare expenditure, the NIP contributed little, ranging between 0.05% and 0.14%. Spending on influenza vaccination increased from € 37 million in 1996 to € 52 million in 2014, while relative to total healthcare expenditure it decreased from 0.069% to 0.055%. In 2014, 0.15% of healthcare expenditure and € 533 per birth was spent on vaccination programmes. Overall, for birth cohorts 1953-1992, € 5.4 thousand (95% confidence interval: 4.0-7.3) was expended per year-of-life-lost averted. CONCLUSION: The actual costs per year-of-life gained are more favorable than estimated here since averted medical costs were not included. Although expenditure on vaccination programmes increased substantially, the contribution to overall healthcare expenditure remained small.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van Wijhe M, de Boer PT, de Jong HJ, et al. Trends in governmental expenditure on vaccination programmes in the Netherlands, a historical analysis. Vaccine. 2019. PMID: 31420172. doi:10.1016/j.vaccine.2019.07.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。